Valuation: Unichem Laboratories Limited

Market Cap 3.72TCr 39Cr 34Cr 31Cr 29Cr 54Cr 55Cr 373.17Cr 146.06Cr 1.82TCr 144.56Cr 141.45Cr 6.28TCr P/E 2025
35.6x
P/E 2026 8.19x
Enterprise Value 3.93TCr 41Cr 36Cr 33Cr 30Cr 57Cr 58Cr 394.32Cr 154.34Cr 1.92TCr 152.76Cr 149.47Cr 6.64TCr EV / Sales 2025
2.49x
EV / Sales 2026 1.03x
Free-Float
28.74%
Yield 2025 *
-
Yield 2026 -
1 day-9.96%
1 week-11.18%
Current month+14.48%
1 month+18.02%
3 months+42.85%
6 months+39.06%
Current year+19.62%
1 week 528.3
Extreme 528.3
615.15
1 month 425.5
Extreme 425.5
687.2
Current year 278.2
Extreme 278.2
687.2
1 year 278.2
Extreme 278.2
687.2
3 years 278.2
Extreme 278.2
937.95
5 years 198
Extreme 198
937.95
10 years 80
Extreme 80
937.95
Manager TitleAgeSince
Chief Executive Officer 57 10/08/2023
Director of Finance/CFO - 08/08/2024
Compliance Officer - -
Director TitleAgeSince
Chairman 73 22/08/1977
Director/Board Member 53 10/08/2023
Director/Board Member 57 10/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
-9.96%-11.18% - - 43Cr
-1.05%+0.55%+49.79%+151.71% 1,04800Cr
+2.00%+3.49%+52.22%+50.20% 60TCr
-1.09%+3.76%+35.37%+76.22% 45TCr
-0.42%+0.67%+30.81%+21.05% 33TCr
-0.16%+2.74%+36.02%+37.33% 28TCr
+1.68%+1.08%+22.70%+17.94% 26TCr
-1.40%-3.34%-24.63%-42.39% 22TCr
-0.05%+2.16%+19.75%+55.89% 20TCr
+0.05%-1.03%+18.31%+61.63% 16TCr
Average -1.25%+1.78%+26.70%+47.73% 39.46TCr
Weighted average by Cap. -0.47%+1.86%+35.85%+72.54%

Financials

2025 2026
Net sales 2.11TCr 22Cr 19Cr 18Cr 16Cr 31Cr 31Cr 211.99Cr 83Cr 1.03TCr 82Cr 80Cr 3.57TCr 2.2TCr 23Cr 20Cr 19Cr 17Cr 32Cr 33Cr 221.11Cr 87Cr 1.08TCr 86Cr 84Cr 3.72TCr
Net income 137.52Cr 1.43Cr 1.25Cr 1.16Cr 1.07Cr 2.01Cr 2.04Cr 14Cr 5.41Cr 67Cr 5.35Cr 5.23Cr 232.46Cr 252.84Cr 2.62Cr 2.3Cr 2.13Cr 1.96Cr 3.69Cr 3.74Cr 25Cr 9.94Cr 123.72Cr 9.84Cr 9.62Cr 427.39Cr
Net Debt 370.19Cr 3.84Cr 3.36Cr 3.12Cr 2.87Cr 5.4Cr 5.48Cr 37Cr 15Cr 181.14Cr 14Cr 14Cr 625.75Cr 210.67Cr 2.18Cr 1.91Cr 1.78Cr 1.63Cr 3.08Cr 3.12Cr 21Cr 8.28Cr 103.08Cr 8.2Cr 8.02Cr 356.1Cr
Logo Unichem Laboratories Limited
Unichem Laboratories Limited is an India-based international, integrated, specialty pharmaceutical company. The Company is focused on product development, process chemistry and manufacturing complex active pharmaceutical ingredients (API) as well as dosage forms. It manufactures and markets pharmaceutical formulations as branded generics as well as generics in several markets across the world. It has several pharma products that address the needs of various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. The Company is also engaged in contract manufacturing with the focus on immediate-release dosage forms, extended-release dosage forms: matrix and pellets, dry powder injections and syrups, novel drug delivery systems, and technology transfer and documentation. Its subsidiaries include Unichem Pharmaceuticals (USA) Inc, Unichem Farmaceutica Do Brasil Lta and Niche Generics Limited UK.
Employees
2,780
Date Price Change Volume
22/26/22 ₹528.55 -9.96% 3,14,223
21/26/21 ₹587.00 -1.44% 59,015
20/26/20 ₹595.60 +1.11% 1,04,166
17/26/17 ₹589.05 -2.61% 1,58,364
16/26/16 ₹604.85 +1.64% 2,69,331